医学
下尿路症状
膀胱过度活动
排尿
度洛西汀
逼尿肌
间质性膀胱炎
前列腺炎
泌尿系统
内科学
前列腺
病理
癌症
替代医学
作者
Russ Chess‐Williams,Catherine McDermott,Donna Sellers,Eliza G. West,Kylie Mills
摘要
Abstract It is well established that lower urinary tract symptoms (LUTS), particularly urinary urgency and incontinence, cause stress and anxiety for patients. However, there is mounting evidence that the relationship between these two factors is bidirectional and that chronic psychological stress itself can result in the development of symptoms such as urinary frequency, urgency, incontinence, and pelvic pain. This review considers the evidence that such a relationship exists and reviews the literature from clinical and animal studies to identify some of the mechanisms that might be involved. Inflammatory responses induced by chronic stress appear to offer the strongest link to bladder dysfunction. There is overwhelming evidence, both in patients and animal models, for a release of pro‐inflammatory cytokines and chemokines during periods of chronic stress. Furthermore, cytokines have been shown to cause bladder dysfunction and pain via actions in the central nervous system and locally in the bladder. In the brain and spinal cord, pro‐inflammatory cytokines influence the regulation of micturition pathways by corticotropin‐releasing factor (CRF) and its receptors, while peripherally cytokines affect bladder function, directly causing detrusor hypertrophy and afferent nerve hypersensitivity. There is little information on which treatments may have most benefit for stressed/anxious patients with LUTS, but animal studies suggest traditional drugs for overactive bladder (solifenacin, mirabegron) are more effective on LUTS than anxiolytic drugs (fluoxetine, imipramine). The preliminary preclinical data for CRF receptor antagonists is not consistent. A clearer understanding of the mechanisms involved in stress‐induced LUTS should provide a basis for improved treatment of this condition.
科研通智能强力驱动
Strongly Powered by AbleSci AI